Ancora Advisors’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $203K | Buy |
4,166
+356
| +9% | +$17.3K | ﹤0.01% | 710 |
|
|
2025
Q1 | $130K | Buy |
3,810
+880
| +30% | +$29.9K | ﹤0.01% | 790 |
|
|
2024
Q4 | $115K | Sell |
2,930
-1,075
| -27% | -$42.3K | ﹤0.01% | 813 |
|
|
2024
Q3 | $188K | Buy |
4,005
+300
| +8% | +$14.1K | ﹤0.01% | 693 |
|
|
2024
Q2 | $200K | Buy |
3,705
+75
| +2% | +$4.05K | 0.01% | 646 |
|
|
2024
Q1 | $247K | Buy |
3,630
+650
| +22% | +$44.3K | 0.01% | 617 |
|
|
2023
Q4 | $187K | Buy |
2,980
+1,650
| +124% | +$103K | ﹤0.01% | 662 |
|
|
2023
Q3 | $60.4K | Buy |
1,330
+700
| +111% | +$31.8K | ﹤0.01% | 849 |
|
|
2023
Q2 | $35.4K | Hold |
630
| – | – | ﹤0.01% | 966 |
|
|
2023
Q1 | $28.5K | Hold |
630
| – | – | ﹤0.01% | 1019 |
|
|
2022
Q4 | $26K | Hold |
630
| – | – | ﹤0.01% | 1078 |
|
|
2022
Q3 | $41K | Hold |
630
| – | – | ﹤0.01% | 1109 |
|
|
2022
Q2 | $38K | Hold |
630
| – | – | ﹤0.01% | 1210 |
|
|
2022
Q1 | $40K | Sell |
630
-1
| -0.2% | -$63 | ﹤0.01% | 1303 |
|
|
2021
Q4 | $48K | Sell |
631
-75
| -11% | -$5.71K | ﹤0.01% | 1290 |
|
|
2021
Q3 | $79K | Sell |
706
-450
| -39% | -$50.4K | ﹤0.01% | 1026 |
|
|
2021
Q2 | $187K | Hold |
1,156
| – | – | ﹤0.01% | 755 |
|
|
2021
Q1 | $141K | Sell |
1,156
-219
| -16% | -$26.7K | ﹤0.01% | 776 |
|
|
2020
Q4 | $211K | Buy |
1,375
+1,025
| +293% | +$157K | 0.01% | 602 |
|
|
2020
Q3 | $29K | Hold |
350
| – | – | ﹤0.01% | 918 |
|
|
2020
Q2 | $26K | Hold |
350
| – | – | ﹤0.01% | 912 |
|
|
2020
Q1 | $15K | Hold |
350
| – | – | ﹤0.01% | 1058 |
|
|
2019
Q4 | $21K | Buy |
+350
| New | +$21K | ﹤0.01% | 1036 |
|